Interestingly, it was reported that in human colon cancer, miR-448 could suppress CD8+ T-cell apoptosis and enhance the CD8+ T-cell response by inhibiting indoleamine 2,3-dioxygenase 1 enzyme function [28]. The gene discussed is CD8A; the disease is malignant colon neoplasm.